January 21, 2025
Fired up for RNA
Chad Pecot, MD, is revolutionizing RNA therapies for cancer through his company EnFuego Therapeutics and the new UNC RNA Discovery Center.
Tag: Chad Pecot
July 2, 2024
UNC RNA Discovery Center retreat further builds community, highlight possibilities
The UNC RNA Discovery Center held its inaugural retreat to bring together its members and trainees to present and discuss RNA science being conducted across UNC-Chapel Hill and beyond.
September 5, 2023
UNC RNA Discovery Center awards inaugural fellowship grants
The UNC RNA Discovery Center has awarded three fellowship grants to support innovative research investigating various roles of RNA in health and disease.
June 28, 2023
NCI awards Pecot $1.8 million lung cancer research grant
The grant will support Chad Pecot, MD, and his research investigating the roles circular RNA may have in regulating whether a form of lung cancer will spread beyond the original cancer site.
April 10, 2023
RNA discoveries drive oncologist’s next chapter
Physician-scientist and cancer survivor Chad Pecot, MD, is focused on RNA discoveries in the lab and the clinic.
February 6, 2023
Lung Cancer Initiative awards Pecot $100,000 grant
The grant supports Chad Pecot, MD, and his research into the mechanistic and therapeutic implications of co-targeting two genes linked to lung cancer.
September 27, 2022
Protein could help identify head and neck cancers that require less intensive treatment
Adding detection of immune cell protein SYNGR3 to current protocols could lead to a more reliable way of determining which patients with head and neck cancer need less intensive treatment.
July 22, 2022
UNC Lineberger creates RNA Discovery Center
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
May 6, 2022
Leading researchers provide insights on aggressive cancers at scientific symposium
UNC Lineberger’s 45th annual Scientific Symposium featured talks on the latest research on pancreatic cancer, tumor microenvironments, metastatic disease and immunotherapy.
March 15, 2022
A patient’s decision adds immeasurably to knowledge about how to treat lung cancer
Chad Pecot, MD, and colleagues used biospecimens from a patient just after he succumbed to lung cancer to unravel how a KRAS mutation developed resistance to a treatment that had initially proved effective.